COMPOUNDING PHARMACIES This content is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment
Who Should Wait GLP-1 may not be appropriate if you're pregnant or breastfeeding, have personal/family history of medullary thyroid cancer, have multiple endocrine neoplasia syndrome type 2, or have active gallbladder disease
Evidence Base: Some peptides have more clinical data than others
Patients should be advised that "GLP-1 probiotic" marketing claims are not FDA-evaluated and may be misleading
Follow-up study of clinical and immunogenetic chracteristics and basal C-peptide in Korea young age onset diabetic patients
Trials administering oral or intravenous arginine and citrulline have reported improvements in uteroplacental hemodynamics and gestational blood-pressure control, without documenting teratogenicity or major maternal complications